カテゴリー： Market Monitor Global, 世界, 医療/バイオ

血液凝固促進剤の世界市場見通し2023年-2029年

◆英語タイトル：Blood Clotting Accelerant Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23JU5725）

◆商品コード：MMG23JU5725
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年6月（※2025年版があります。お問い合わせください。）
◆ページ数：72
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医薬品＆医療

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥468,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥608,400	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥702,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Blood Clotting Accelerant Market 調査レポートは次の情報を含め、グローバルにおけるの血液凝固促進剤市場規模と予測を収録しています。・世界の血液凝固促進剤市場：売上、2018年-2023年、2024年-2029年
・世界の血液凝固促進剤市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の血液凝固促進剤市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「粉末」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

血液凝固促進剤のグローバル主要企業は、Merck KgaA、 Baxter International Inc、 CSL Ltd., Inc.、 Grifols International SA、 Kedrion S.P.A.、 Novo Nordisk A/S、 Octapharma AG、 PeproTech, Inc.、 ACROBiosystemsなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、血液凝固促進剤のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の血液凝固促進剤市場：タイプ別、2018年-2023年、2024年-2029年
世界の血液凝固促進剤市場：タイプ別市場シェア、2022年
・粉末、溶液

世界の血液凝固促進剤市場：用途別、2018年-2023年、2024年-2029年
世界の血液凝固促進剤市場：用途別市場シェア、2022年
・病院、専門診療所、検査機関、研究機関

世界の血液凝固促進剤市場：地域・国別、2018年-2023年、2024年-2029年
世界の血液凝固促進剤市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における血液凝固促進剤のグローバル売上、2018年-2023年
・主要企業における血液凝固促進剤のグローバル売上シェア、2022年
・主要企業における血液凝固促進剤のグローバル販売量、2018年-2023年
・主要企業における血液凝固促進剤のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Merck KgaA、 Baxter International Inc、 CSL Ltd., Inc.、 Grifols International SA、 Kedrion S.P.A.、 Novo Nordisk A/S、 Octapharma AG、 PeproTech, Inc.、 ACROBiosystems

*************************************************************

・調査・分析レポートの概要
血液凝固促進剤市場の定義
市場セグメント
世界の血液凝固促進剤市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の血液凝固促進剤市場規模
世界の血液凝固促進剤市場規模：2022年 VS 2029年
世界の血液凝固促進剤市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの血液凝固促進剤の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の血液凝固促進剤製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：粉末、溶液
血液凝固促進剤のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、専門診療所、検査機関、研究機関
血液凝固促進剤の用途別グローバル売上・予測

・地域別市場分析
地域別血液凝固促進剤市場規模 2022年と2029年
地域別血液凝固促進剤売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Merck KgaA、 Baxter International Inc、 CSL Ltd., Inc.、 Grifols International SA、 Kedrion S.P.A.、 Novo Nordisk A/S、 Octapharma AG、 PeproTech, Inc.、 ACROBiosystems
...

Blood clotting accelerants are used to enhance the process of blood clotting within a shorter period of time than it would require normally. Blood clotting is a complex mechanism which involves various factors and normal coagulation functioning in a patient is screened by tests prior to surgeries. The use of blood clotting accelerant is increasing in clinical spheres as a result of increasing incidence of conditions like hemophilia, anemia, thrombolysis, pulmonary embolism (PE), deep vein thrombosis (DVT), liver diseases, surgical treatments and genetically inherited deficiencies which impede normal coagulation process and can be confirmed via blood clotting accelerants. According to the National Hemophilia Foundation, von Willebrand disease affects up to 1% of US population. Current gene therapy research trials are focused on methods to insert factor VIII genes into hemophilic patients to restore normal coagulation functioning.
This report aims to provide a comprehensive presentation of the global market for Blood Clotting Accelerant, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Blood Clotting Accelerant. This report contains market size and forecasts of Blood Clotting Accelerant in global, including the following market information:
Global Blood Clotting Accelerant Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Blood Clotting Accelerant Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Blood Clotting Accelerant companies in 2022 (%)
The global Blood Clotting Accelerant market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Powder Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Blood Clotting Accelerant include Merck KgaA, Baxter International Inc, CSL Ltd., Inc., Grifols International SA, Kedrion S.P.A., Novo Nordisk A/S, Octapharma AG, PeproTech, Inc. and ACROBiosystems, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Blood Clotting Accelerant manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Blood Clotting Accelerant Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Blood Clotting Accelerant Market Segment Percentages, by Type, 2022 (%)
Powder
Solution
Global Blood Clotting Accelerant Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Blood Clotting Accelerant Market Segment Percentages, by Application, 2022 (%)
Hospitals
Specialty Clinics
Diagnostic Laboratories
Research Institutes
Global Blood Clotting Accelerant Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Blood Clotting Accelerant Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Blood Clotting Accelerant revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Blood Clotting Accelerant revenues share in global market, 2022 (%)
Key companies Blood Clotting Accelerant sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Blood Clotting Accelerant sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck KgaA
Baxter International Inc
CSL Ltd., Inc.
Grifols International SA
Kedrion S.P.A.
Novo Nordisk A/S
Octapharma AG
PeproTech, Inc.
ACROBiosystems
Outline of Major Chapters:
Chapter 1: Introduces the definition of Blood Clotting Accelerant, market overview.
Chapter 2: Global Blood Clotting Accelerant market size in revenue and volume.
Chapter 3: Detailed analysis of Blood Clotting Accelerant manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Blood Clotting Accelerant in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Blood Clotting Accelerant capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Blood Clotting Accelerant Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Blood Clotting Accelerant Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Blood Clotting Accelerant Overall Market Size
2.1 Global Blood Clotting Accelerant Market Size: 2022 VS 2029
2.2 Global Blood Clotting Accelerant Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Blood Clotting Accelerant Sales: 2018-2029
3 Company Landscape
3.1 Top Blood Clotting Accelerant Players in Global Market
3.2 Top Global Blood Clotting Accelerant Companies Ranked by Revenue
3.3 Global Blood Clotting Accelerant Revenue by Companies
3.4 Global Blood Clotting Accelerant Sales by Companies
3.5 Global Blood Clotting Accelerant Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Blood Clotting Accelerant Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Blood Clotting Accelerant Product Type
3.8 Tier 1, Tier 2 and Tier 3 Blood Clotting Accelerant Players in Global Market
3.8.1 List of Global Tier 1 Blood Clotting Accelerant Companies
3.8.2 List of Global Tier 2 and Tier 3 Blood Clotting Accelerant Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Blood Clotting Accelerant Market Size Markets, 2022 & 2029
4.1.2 Powder
4.1.3 Solution
4.2 By Type – Global Blood Clotting Accelerant Revenue & Forecasts
4.2.1 By Type – Global Blood Clotting Accelerant Revenue, 2018-2023
4.2.2 By Type – Global Blood Clotting Accelerant Revenue, 2024-2029
4.2.3 By Type – Global Blood Clotting Accelerant Revenue Market Share, 2018-2029
4.3 By Type – Global Blood Clotting Accelerant Sales & Forecasts
4.3.1 By Type – Global Blood Clotting Accelerant Sales, 2018-2023
4.3.2 By Type – Global Blood Clotting Accelerant Sales, 2024-2029
4.3.3 By Type – Global Blood Clotting Accelerant Sales Market Share, 2018-2029
4.4 By Type – Global Blood Clotting Accelerant Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Blood Clotting Accelerant Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Specialty Clinics
5.1.4 Diagnostic Laboratories
5.1.5 Research Institutes
5.2 By Application – Global Blood Clotting Accelerant Revenue & Forecasts
5.2.1 By Application – Global Blood Clotting Accelerant Revenue, 2018-2023
5.2.2 By Application – Global Blood Clotting Accelerant Revenue, 2024-2029
5.2.3 By Application – Global Blood Clotting Accelerant Revenue Market Share, 2018-2029
5.3 By Application – Global Blood Clotting Accelerant Sales & Forecasts
5.3.1 By Application – Global Blood Clotting Accelerant Sales, 2018-2023
5.3.2 By Application – Global Blood Clotting Accelerant Sales, 2024-2029
5.3.3 By Application – Global Blood Clotting Accelerant Sales Market Share, 2018-2029
5.4 By Application – Global Blood Clotting Accelerant Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Blood Clotting Accelerant Market Size, 2022 & 2029
6.2 By Region – Global Blood Clotting Accelerant Revenue & Forecasts
6.2.1 By Region – Global Blood Clotting Accelerant Revenue, 2018-2023
6.2.2 By Region – Global Blood Clotting Accelerant Revenue, 2024-2029
6.2.3 By Region – Global Blood Clotting Accelerant Revenue Market Share, 2018-2029
6.3 By Region – Global Blood Clotting Accelerant Sales & Forecasts
6.3.1 By Region – Global Blood Clotting Accelerant Sales, 2018-2023
6.3.2 By Region – Global Blood Clotting Accelerant Sales, 2024-2029
6.3.3 By Region – Global Blood Clotting Accelerant Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Blood Clotting Accelerant Revenue, 2018-2029
6.4.2 By Country – North America Blood Clotting Accelerant Sales, 2018-2029
6.4.3 US Blood Clotting Accelerant Market Size, 2018-2029
6.4.4 Canada Blood Clotting Accelerant Market Size, 2018-2029
6.4.5 Mexico Blood Clotting Accelerant Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Blood Clotting Accelerant Revenue, 2018-2029
6.5.2 By Country – Europe Blood Clotting Accelerant Sales, 2018-2029
6.5.3 Germany Blood Clotting Accelerant Market Size, 2018-2029
6.5.4 France Blood Clotting Accelerant Market Size, 2018-2029
6.5.5 U.K. Blood Clotting Accelerant Market Size, 2018-2029
6.5.6 Italy Blood Clotting Accelerant Market Size, 2018-2029
6.5.7 Russia Blood Clotting Accelerant Market Size, 2018-2029
6.5.8 Nordic Countries Blood Clotting Accelerant Market Size, 2018-2029
6.5.9 Benelux Blood Clotting Accelerant Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Blood Clotting Accelerant Revenue, 2018-2029
6.6.2 By Region – Asia Blood Clotting Accelerant Sales, 2018-2029
6.6.3 China Blood Clotting Accelerant Market Size, 2018-2029
6.6.4 Japan Blood Clotting Accelerant Market Size, 2018-2029
6.6.5 South Korea Blood Clotting Accelerant Market Size, 2018-2029
6.6.6 Southeast Asia Blood Clotting Accelerant Market Size, 2018-2029
6.6.7 India Blood Clotting Accelerant Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Blood Clotting Accelerant Revenue, 2018-2029
6.7.2 By Country – South America Blood Clotting Accelerant Sales, 2018-2029
6.7.3 Brazil Blood Clotting Accelerant Market Size, 2018-2029
6.7.4 Argentina Blood Clotting Accelerant Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Blood Clotting Accelerant Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Blood Clotting Accelerant Sales, 2018-2029
6.8.3 Turkey Blood Clotting Accelerant Market Size, 2018-2029
6.8.4 Israel Blood Clotting Accelerant Market Size, 2018-2029
6.8.5 Saudi Arabia Blood Clotting Accelerant Market Size, 2018-2029
6.8.6 UAE Blood Clotting Accelerant Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Merck KgaA
7.1.1 Merck KgaA Company Summary
7.1.2 Merck KgaA Business Overview
7.1.3 Merck KgaA Blood Clotting Accelerant Major Product Offerings
7.1.4 Merck KgaA Blood Clotting Accelerant Sales and Revenue in Global (2018-2023)
7.1.5 Merck KgaA Key News & Latest Developments
7.2 Baxter International Inc
7.2.1 Baxter International Inc Company Summary
7.2.2 Baxter International Inc Business Overview
7.2.3 Baxter International Inc Blood Clotting Accelerant Major Product Offerings
7.2.4 Baxter International Inc Blood Clotting Accelerant Sales and Revenue in Global (2018-2023)
7.2.5 Baxter International Inc Key News & Latest Developments
7.3 CSL Ltd., Inc.
7.3.1 CSL Ltd., Inc. Company Summary
7.3.2 CSL Ltd., Inc. Business Overview
7.3.3 CSL Ltd., Inc. Blood Clotting Accelerant Major Product Offerings
7.3.4 CSL Ltd., Inc. Blood Clotting Accelerant Sales and Revenue in Global (2018-2023)
7.3.5 CSL Ltd., Inc. Key News & Latest Developments
7.4 Grifols International SA
7.4.1 Grifols International SA Company Summary
7.4.2 Grifols International SA Business Overview
7.4.3 Grifols International SA Blood Clotting Accelerant Major Product Offerings
7.4.4 Grifols International SA Blood Clotting Accelerant Sales and Revenue in Global (2018-2023)
7.4.5 Grifols International SA Key News & Latest Developments
7.5 Kedrion S.P.A.
7.5.1 Kedrion S.P.A. Company Summary
7.5.2 Kedrion S.P.A. Business Overview
7.5.3 Kedrion S.P.A. Blood Clotting Accelerant Major Product Offerings
7.5.4 Kedrion S.P.A. Blood Clotting Accelerant Sales and Revenue in Global (2018-2023)
7.5.5 Kedrion S.P.A. Key News & Latest Developments
7.6 Novo Nordisk A/S
7.6.1 Novo Nordisk A/S Company Summary
7.6.2 Novo Nordisk A/S Business Overview
7.6.3 Novo Nordisk A/S Blood Clotting Accelerant Major Product Offerings
7.6.4 Novo Nordisk A/S Blood Clotting Accelerant Sales and Revenue in Global (2018-2023)
7.6.5 Novo Nordisk A/S Key News & Latest Developments
7.7 Octapharma AG
7.7.1 Octapharma AG Company Summary
7.7.2 Octapharma AG Business Overview
7.7.3 Octapharma AG Blood Clotting Accelerant Major Product Offerings
7.7.4 Octapharma AG Blood Clotting Accelerant Sales and Revenue in Global (2018-2023)
7.7.5 Octapharma AG Key News & Latest Developments
7.8 PeproTech, Inc.
7.8.1 PeproTech, Inc. Company Summary
7.8.2 PeproTech, Inc. Business Overview
7.8.3 PeproTech, Inc. Blood Clotting Accelerant Major Product Offerings
7.8.4 PeproTech, Inc. Blood Clotting Accelerant Sales and Revenue in Global (2018-2023)
7.8.5 PeproTech, Inc. Key News & Latest Developments
7.9 ACROBiosystems
7.9.1 ACROBiosystems Company Summary
7.9.2 ACROBiosystems Business Overview
7.9.3 ACROBiosystems Blood Clotting Accelerant Major Product Offerings
7.9.4 ACROBiosystems Blood Clotting Accelerant Sales and Revenue in Global (2018-2023)
7.9.5 ACROBiosystems Key News & Latest Developments
8 Global Blood Clotting Accelerant Production Capacity, Analysis
8.1 Global Blood Clotting Accelerant Production Capacity, 2018-2029
8.2 Blood Clotting Accelerant Production Capacity of Key Manufacturers in Global Market
8.3 Global Blood Clotting Accelerant Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Blood Clotting Accelerant Supply Chain Analysis
10.1 Blood Clotting Accelerant Industry Value Chain
10.2 Blood Clotting Accelerant Upstream Market
10.3 Blood Clotting Accelerant Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Blood Clotting Accelerant Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Blood Clotting Accelerant in Global Market
Table 2. Top Blood Clotting Accelerant Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Blood Clotting Accelerant Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Blood Clotting Accelerant Revenue Share by Companies, 2018-2023
Table 5. Global Blood Clotting Accelerant Sales by Companies, (K Units), 2018-2023
Table 6. Global Blood Clotting Accelerant Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Blood Clotting Accelerant Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Blood Clotting Accelerant Product Type
Table 9. List of Global Tier 1 Blood Clotting Accelerant Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Blood Clotting Accelerant Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Blood Clotting Accelerant Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Blood Clotting Accelerant Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Blood Clotting Accelerant Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Blood Clotting Accelerant Sales (K Units), 2018-2023
Table 15. By Type - Global Blood Clotting Accelerant Sales (K Units), 2024-2029
Table 16. By Application – Global Blood Clotting Accelerant Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Blood Clotting Accelerant Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Blood Clotting Accelerant Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Blood Clotting Accelerant Sales (K Units), 2018-2023
Table 20. By Application - Global Blood Clotting Accelerant Sales (K Units), 2024-2029
Table 21. By Region – Global Blood Clotting Accelerant Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Blood Clotting Accelerant Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Blood Clotting Accelerant Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Blood Clotting Accelerant Sales (K Units), 2018-2023
Table 25. By Region - Global Blood Clotting Accelerant Sales (K Units), 2024-2029
Table 26. By Country - North America Blood Clotting Accelerant Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Blood Clotting Accelerant Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Blood Clotting Accelerant Sales, (K Units), 2018-2023
Table 29. By Country - North America Blood Clotting Accelerant Sales, (K Units), 2024-2029
Table 30. By Country - Europe Blood Clotting Accelerant Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Blood Clotting Accelerant Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Blood Clotting Accelerant Sales, (K Units), 2018-2023
Table 33. By Country - Europe Blood Clotting Accelerant Sales, (K Units), 2024-2029
Table 34. By Region - Asia Blood Clotting Accelerant Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Blood Clotting Accelerant Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Blood Clotting Accelerant Sales, (K Units), 2018-2023
Table 37. By Region - Asia Blood Clotting Accelerant Sales, (K Units), 2024-2029
Table 38. By Country - South America Blood Clotting Accelerant Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Blood Clotting Accelerant Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Blood Clotting Accelerant Sales, (K Units), 2018-2023
Table 41. By Country - South America Blood Clotting Accelerant Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Blood Clotting Accelerant Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Blood Clotting Accelerant Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Blood Clotting Accelerant Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Blood Clotting Accelerant Sales, (K Units), 2024-2029
Table 46. Merck KgaA Company Summary
Table 47. Merck KgaA Blood Clotting Accelerant Product Offerings
Table 48. Merck KgaA Blood Clotting Accelerant Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Merck KgaA Key News & Latest Developments
Table 50. Baxter International Inc Company Summary
Table 51. Baxter International Inc Blood Clotting Accelerant Product Offerings
Table 52. Baxter International Inc Blood Clotting Accelerant Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Baxter International Inc Key News & Latest Developments
Table 54. CSL Ltd., Inc. Company Summary
Table 55. CSL Ltd., Inc. Blood Clotting Accelerant Product Offerings
Table 56. CSL Ltd., Inc. Blood Clotting Accelerant Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. CSL Ltd., Inc. Key News & Latest Developments
Table 58. Grifols International SA Company Summary
Table 59. Grifols International SA Blood Clotting Accelerant Product Offerings
Table 60. Grifols International SA Blood Clotting Accelerant Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Grifols International SA Key News & Latest Developments
Table 62. Kedrion S.P.A. Company Summary
Table 63. Kedrion S.P.A. Blood Clotting Accelerant Product Offerings
Table 64. Kedrion S.P.A. Blood Clotting Accelerant Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Kedrion S.P.A. Key News & Latest Developments
Table 66. Novo Nordisk A/S Company Summary
Table 67. Novo Nordisk A/S Blood Clotting Accelerant Product Offerings
Table 68. Novo Nordisk A/S Blood Clotting Accelerant Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Novo Nordisk A/S Key News & Latest Developments
Table 70. Octapharma AG Company Summary
Table 71. Octapharma AG Blood Clotting Accelerant Product Offerings
Table 72. Octapharma AG Blood Clotting Accelerant Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Octapharma AG Key News & Latest Developments
Table 74. PeproTech, Inc. Company Summary
Table 75. PeproTech, Inc. Blood Clotting Accelerant Product Offerings
Table 76. PeproTech, Inc. Blood Clotting Accelerant Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. PeproTech, Inc. Key News & Latest Developments
Table 78. ACROBiosystems Company Summary
Table 79. ACROBiosystems Blood Clotting Accelerant Product Offerings
Table 80. ACROBiosystems Blood Clotting Accelerant Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. ACROBiosystems Key News & Latest Developments
Table 82. Blood Clotting Accelerant Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 83. Global Blood Clotting Accelerant Capacity Market Share of Key Manufacturers, 2021-2023
Table 84. Global Blood Clotting Accelerant Production by Region, 2018-2023 (K Units)
Table 85. Global Blood Clotting Accelerant Production by Region, 2024-2029 (K Units)
Table 86. Blood Clotting Accelerant Market Opportunities & Trends in Global Market
Table 87. Blood Clotting Accelerant Market Drivers in Global Market
Table 88. Blood Clotting Accelerant Market Restraints in Global Market
Table 89. Blood Clotting Accelerant Raw Materials
Table 90. Blood Clotting Accelerant Raw Materials Suppliers in Global Market
Table 91. Typical Blood Clotting Accelerant Downstream
Table 92. Blood Clotting Accelerant Downstream Clients in Global Market
Table 93. Blood Clotting Accelerant Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Blood Clotting Accelerant Segment by Type in 2022
Figure 2. Blood Clotting Accelerant Segment by Application in 2022
Figure 3. Global Blood Clotting Accelerant Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Blood Clotting Accelerant Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Blood Clotting Accelerant Revenue, 2018-2029 (US$, Mn)
Figure 7. Blood Clotting Accelerant Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Blood Clotting Accelerant Revenue in 2022
Figure 9. By Type - Global Blood Clotting Accelerant Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Blood Clotting Accelerant Revenue Market Share, 2018-2029
Figure 11. By Type - Global Blood Clotting Accelerant Sales Market Share, 2018-2029
Figure 12. By Type - Global Blood Clotting Accelerant Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Blood Clotting Accelerant Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Blood Clotting Accelerant Revenue Market Share, 2018-2029
Figure 15. By Application - Global Blood Clotting Accelerant Sales Market Share, 2018-2029
Figure 16. By Application - Global Blood Clotting Accelerant Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Blood Clotting Accelerant Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Blood Clotting Accelerant Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Blood Clotting Accelerant Revenue Market Share, 2018-2029
Figure 20. By Region - Global Blood Clotting Accelerant Sales Market Share, 2018-2029
Figure 21. By Country - North America Blood Clotting Accelerant Revenue Market Share, 2018-2029
Figure 22. By Country - North America Blood Clotting Accelerant Sales Market Share, 2018-2029
Figure 23. US Blood Clotting Accelerant Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Blood Clotting Accelerant Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Blood Clotting Accelerant Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Blood Clotting Accelerant Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Blood Clotting Accelerant Sales Market Share, 2018-2029
Figure 28. Germany Blood Clotting Accelerant Revenue, (US$, Mn), 2018-2029
Figure 29. France Blood Clotting Accelerant Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Blood Clotting Accelerant Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Blood Clotting Accelerant Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Blood Clotting Accelerant Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Blood Clotting Accelerant Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Blood Clotting Accelerant Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Blood Clotting Accelerant Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Blood Clotting Accelerant Sales Market Share, 2018-2029
Figure 37. China Blood Clotting Accelerant Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Blood Clotting Accelerant Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Blood Clotting Accelerant Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Blood Clotting Accelerant Revenue, (US$, Mn), 2018-2029
Figure 41. India Blood Clotting Accelerant Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Blood Clotting Accelerant Revenue Market Share, 2018-2029
Figure 43. By Country - South America Blood Clotting Accelerant Sales Market Share, 2018-2029
Figure 44. Brazil Blood Clotting Accelerant Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Blood Clotting Accelerant Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Blood Clotting Accelerant Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Blood Clotting Accelerant Sales Market Share, 2018-2029
Figure 48. Turkey Blood Clotting Accelerant Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Blood Clotting Accelerant Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Blood Clotting Accelerant Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Blood Clotting Accelerant Revenue, (US$, Mn), 2018-2029
Figure 52. Global Blood Clotting Accelerant Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Blood Clotting Accelerant by Region, 2022 VS 2029
Figure 54. Blood Clotting Accelerant Industry Value Chain
Figure 55. Marketing Channels

※参考情報

血液凝固促進剤は、血液が凝固する過程を促すための薬剤や物質を指します。このような薬剤は、外傷や手術、大出血などの状況において、血液の凝固を早めることで出血を抑える役割を果たします。血液凝固は人体の重要な生理的プロセスであり、出血が起こった際に体が自らを防御するためのメカニズムです。ところが、特定の状況や疾患においてはこの過程が正常に機能しないことがあり、そこで血液凝固促進剤の出番となります。

まず、血液凝固促進剤の定義について考察します。血液凝固とは、血液が液体から固体へと変化する過程であり、主に血小板や凝固因子が関与しています。血液凝固促進剤は、この過程を補助するために用いられ、出血の速度を緩和する役割を担っています。具体的には、血小板の活性化を促進したり、血液中の凝固因子の機能を調整したりすることで、血液の凝固を助けるのです。

続いて、血液凝固促進剤の特徴について述べます。血液凝固促進剤は、その作用機序や対象となる状況によって、様々な種類があります。一般的には、高い安全性と特異性が求められます。また、血液凝固促進剤は多くの場合、迅速に作用することが求められるため、注射による投与が一般的です。これにより、急な出血の際にも速やかに効果を発揮できます。しかし、血栓形成を助長することがあるため、その使用には注意が必要です。また、過剰使用や誤った使用は、逆に血栓症や心血管疾患のリスクを高める可能性があるため、医師の指導のもとで使用されるべきです。

血液凝固促進剤には、いくつかの種類があります。最も一般的なものには、トロンビンやフィブリノゲン、凝固因子VIIIなどがあります。トロンビンは、血液中でフィブリンを生成する基盤となる酵素であり、血小板を活性化し、凝固プロセスを加速します。また、フィブリノゲンは血液の凝固において重要な役割を持つタンパク質で、トロンビンによってフィブリンに変換され、血液の塊を作る材料となります。凝固因子VIIIは、主に凝固カスケードに関与しており、血液の正常な凝固を支える重要な成分です。

これらの促進剤は、さまざまな用途に活用されます。例えば、外科手術や歯科治療、外傷治療において、出血を抑えるために使用されることが一般的です。また、血液凝固異常に関連する病気、例えば血友病や肝疾患の治療においても重要な役割を担っています。これにより、患者のQOL（生活の質）の向上が図られています。さらに、これらの薬剤は救急医療の現場でも頻繁に用いられます。例えば、交通事故やスポーツによる外傷時には、即時に出血を制御するために最優先で使用されることが多いです。

関連技術についても触れておきます。血液凝固促進剤の開発には、バイオテクノロジーや分子生物学の進歩が直接寄与しています。特に、遺伝子工学を用いた新しい凝固因子の製造や、より効果的な促進剤の探索は、今後の医療において重要な課題とされています。最近では、ナノテクノロジーやマイクロ流体デバイスも応用され、血液凝固のメカニズムを理解し、より精密に制御する試みも進められています。

加えて、血液凝固促進剤の使用には副作用やリスクが伴います。特に、出血傾向がある患者や、血栓症リスクが高い患者に対しては、使用が慎重となる場合があります。そのため、医療従事者は患者の状態を正確に評価し、適切な治療法を選択する必要があります。また、血液凝固の調節には多くの要因が関与しているため、凝固因子のバランスを取ることが重要です。近年、個別化医療の観点から、患者ごとの遺伝子や生理的特性に基づいた治療が模索されています。これにより、より安全で有効な治療方法が提供されることが期待されます。

血液凝固促進剤は、医療現場において重要な役割を果たす一方で、その使用には細心の注意が必要です。医療従事者は、患者の状態やリスクを考慮しながら、最適な選択を行うことが求められます。今後も科学の進展により、より効果的かつ安全な血液凝固促進剤の開発が期待されており、これにより多くの患者の命が救われることでしょう。また、血液凝固のメカニズムを理解することで、新たな治療法の開発へとつながる可能性も秘めています。医療の進歩は止まることがなく、今後の展開が非常に楽しみです。

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 血液凝固促進剤の世界市場見通し2023年-2029年(Blood Clotting Accelerant Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

血液凝固促進剤の世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp